Filing Flows › Ocugen (OCGN) › Q3 2026 › vs Q3 2025
Ocugen (OCGN) Q3 2026 vs Q3 2025 (year over year)
Ocugen's revenue rose $199K (+11%) from $1.8M in Q3 2025 to $2.0M in Q3 2026.
Ocugen, Q3 2026: revenue $2.0M (+11% year over year), operating margin -909.9%, net loss $3.6M, operating cash flow −$15.7M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.0M | $1.8M | $199K | +11% |
| Other income, net | $14.2M | −$2.4M | $16.6M | — |
| Net loss | $3.6M | $20.1M | −$16.5M | -82% |
| Costs & expenses | $19.7M | $21.8M | −$2.1M | -10% |
| Operating costs | $19.7M | $19.4M | $327K | +2% |
| Research & development | $12.5M | $11.1M | $1.4M | +12% |
| General & admin | $7.2M | $8.2M | −$1.0M | -12% |
| Operating cash sources | $18.2M | $15.5M | $2.7M | +17% |
| Depreciation | $500K | $600K | −$100K | -17% |
| Share-based compensation | $2.0M | $2.0M | −$21K | -1% |
| Cash used in operations | $15.7M | $12.9M | $2.8M | +22% |
| Net loss absorbed | $3.6M | $20.1M | −$16.5M | -82% |
| Working capital & other | $14.6M | −$4.6M | $19.2M | — |
Questions
How much did Ocugen's revenue grow year over year in Q3 2026?
Ocugen's revenue rose $199K (+11%) from $1.8M in Q3 2025 to $2.0M in Q3 2026.